Pusic I, Miklos D, Cutler C, et al. Ibrutinib for chronic graft-versus-host disease after failure of frontline corticosteroids: results of a multicenter open-label phase 2-study. EHA 2017, S492.
FDA keurt bosutinib goed voor behandeling kinderen met CML
dec 2023 | Leukemie